R1

More than half had silent atherosclerosis. Standard risk scores missed many of them

AstraZeneca’s Wainua lowered a disease-causing protein but did not reduce heart complications in a major trial

FDA Is Asking the Right AI Question: Who Watches the Model After Approval?

The same weight loss produced different metabolic benefits. Diet quality may matter as much as kilograms lost

Endometrial Cancer Prehab Should Not Be a Luxury Experiment

Dermatophilus Changed Pattern.

AI can find hidden heart disease in routine ECGs. The policy challenge is deciding who gets fast-tracked

Radiopharmaceuticals Just Got a Necessary No

Sprint interval training triggered a bigger molecular response than 90 minutes of cycling. Bigger is not yet better
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
